Диссертация (1154706), страница 15
Текст из файла (страница 15)
// Ann Hepatol. - 2011. - № 10.109- C. 321–6.143. Ota K. Effects of nifedipine on hepatic venous pressure gradient and portal veinblood flow in patients with cirrhosis // Journal of Gastroenterology and Hepatology. 1995. - № 2 (10). - C. 198–204.144. Parker M., Puddey I.B., Beilin L.J. A 2-way factorial study of alcohol and saltrestriction in treated hypertensive men. // Hypertension. -1990. - (6). - C. 398–406.145. Pavec J., Souza R. Le Portopulmonary hypertension: survival and prognosticfactors.
// Am. J. Respir. Crit. Care Med. - 2008. - (178). - C. 637–43.146. Pavec J. Portopulmonary Hypertension // American Journal of Respiratory andCritical Care Medicine.- 2008. - № 6 (178).- C. 637–643.147. Pellicelli A.M. Plasma Cytokines and Portopulmonary Hypertension in PatientsWith Cirrhosis Waiting for Orthotopic Liver Transplantation // Angiology.- 2010.№ 8 (61).
- C. 802–806.148. Petrocellis L, Cascio M. De The endocannabinoid system: a general view andlatest additions. // Br J Pharmacol. - 2004.- № 141. - C. 765–74.149. Porres-Aguilar M. Portopulmonary hypertension and hepatopulmonarysyndrome: a clinician-oriented overview // European Respiratory Review.- 2012. - №125 (21). - C. 223–233.150. Porres-Aguilar M., Duarte-Rojo A., Krowka M.J.
Transthoracicechocardiography screening for the detection of portopulmonary hypertension: Awork in progress // Liver Transplantation. - 2013.- № 6 (19). - C. 573–574.151. Pozzi, M., Carugo, S., Boari, G., Pecci, V., de Ceglia, S., Maggiolini S.Evidence of functional and structural cardiac abnormalities in cirrhotic patients withand without ascites // Hepatology. - 1997.- № 26.- C.
1131–1137.152. Puddey I.B., Beilin L.J., Vandongen R., Rouse I.L. Evidence of a direct effect ofalcohol consumption on blood pressure in normotensive men: a randomizedcontrolled trial. // Hypertension. - 1985. - № 7. - C. 707–13.153. Raevens S. Echocardiography for the detection of portopulmonary hypertensionin liver transplant candidates: An analysis of cutoff values // Liver Transplantation.1102013.- № 6 (19).- C. 602–610.154. Rayes N., Bechstein W.O., Keck H., Blumhardt G., Lohmann R. Causes ofdeath after liver transplantation: an analysis of 41 cases in 382 patients.
// ZentralblattChir.- 1995.- № 120. - C. 435–438.155. Altekin R., Caglar B., Karakas M., Ozel D. Evaluation of Subclinical LeftVentricular Systolic Dysfunction Using Two-Dimensional Speckle- TrackingEchocardiography in Patients with Non - Alcoholic Cirrhosis // Hellenic J Cardiol.2014. - № 55. - C. 402–410.156. Regan T.J., Levinson G.E., Oldewurtel H.A., Frank M.J., Weisse A.B.Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in theproduction of cardiomyopathy. // J Clin Invest.
- 1969. - C. 397–407.157. Robalino B.D., Moodie D.S. Association between primary pulmonaryhypertension and portal hypertension: Analysis of its pathophysiology and clinical,laboratory and hemodynamic manifestations // Journal of the American College ofCardiology. - 1991. - № 2 (17). - C. 492–498.158. Rodriguez-Roisin R. Pulmonary-Hepatic vascular Disorders (PHD) // EuropeanRespiratory Journal. - 2004. - № 5 (24).
- C. 861–880.159. Rotondo S. The relationship between wine consumption and cardiovascular risk:from epidemiological evidence to biological plausibility. // Ital. Heart. J. - 2001. - №1 (2). C. 1–8.160. Ruiz-del-Arbol L. Circulatory function and hepatorenal syndrome in cirrhosis //Hepatology. - 2005. - № 2 (42). - C.
439–447.161. Saito K. Comprehensive Evaluation of Left Ventricular Strain Using SpeckleTracking Echocardiography in Normal Adults: Comparison of Three-Dimensionaland Two-Dimensional Approaches // Journal of the American Society ofEchocardiography.- 2009. - № 9 (22). - C.
1025–1030.162. Sampaio F., Pimenta J., Bettencourt N., Fontes-Carvalho R., Silva AP., ValenteJ., Bettencourt P., Fraga J. Systolic and diastolic dysfunction in cirrhosis: a tissueDoppler and speckle tracking echocardiography study // Liver Int. - 2013. - № 33 (8).111- C. 1158–65.163. Simonneau G.
Updated Clinical Classification of Pulmonary Hypertension //Journal of the American College of Cardiology. - 2013. - № 25 (62). - C. D34–D41.164. Sitbon O. Long-Term Response to Calcium Channel Blockers in IdiopathicPulmonary Arterial Hypertension // Circulation. - 2005. - № 23 (111). - C. 3105–3111.165. Skipper, B., Luo, W., Griffith J. Intracardiac and intrarenal renin-angiotensinsystems: mechanisms of cardiovascular and renal effects.
// J Investig Med. - 2007. № 55. - C. 341–359.166. Spatt S.D. The incidence of hypertension in portal cirrhosis: a study of 80necropsied cases of portal cirrhosis. // Ann Intern Med. - 1949. - № 31. - C. 479–483.167. Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E. Prospective study ofmoderate alcohol consumption and the risk of coronary disease and stroke in women.// N Engl J Med.
- 1988. - (319). - C. 267–71.168. Sterk P.J. Standardized challenge testing with pharmacological, physical andsensitizing stimuli in adults // European Respiratory Journal. - 1993. - № Suppl 16(6).- C. 53–83.169. Sun F.-R. Relationship between model for end-stage liver disease score and leftventricular function in patients with end-stage liver disease // Hepatobiliary &Pancreatic Diseases International.- 2011. - № 1 (10). - C. 50–54.170.
Swanson K.L. Survival in Portopulmonary Hypertension: Mayo ClinicExperience Categorized by Treatment Subgroups // American Journal ofTransplantation. - 2008. - № 11 (8). - C. 2445–2453.171. Swanson K.L., Krowka M.J. Arterial Oxygenation Associated WithPortopulmonary Hypertension // Chest. - 2002. - № 6 (121). - C. 1869–1875.172. Talwalkar J.A. Prevalence of Spontaneous Portosystemic Shunts in PatientsWith Portopulmonary Hypertension and Effect on Treatment // Gastroenterology.2011.
- № 5 (141). - C. 1673–1679.173. Teuber G. Pulmonary dysfunction in non-cirrhotic patients with chronic viral112hepatitis // European Journal of Internal Medicine. - 2002. - № 5 (13). - C. 311–318.174. Therapondos G., Flapan A. D., Plevris J. N.Cardiac morbidity and mortalityrelated to orthotopic liver transplantation // Liver Transpl.- 2004. - № 10. - C. 1441–1453.175. Torregrosa M., Aguadé S., Dos L., Segura R., Gonzalez A. Cardiac alterations incirrhosis: reversibility after liver transplantation // Hepatology. - 2005.
- № 42. - C.68–74.176.Tuder R.M. Prostacyclin Synthase Expression Is Decreased in Lungs fromPatients with Severe Pulmonary Hypertension // American Journal of Respiratory andCritical Care Medicine. - 1999. - № 6 (159). - C. 1925–1932.177.
Turnet Ch. Alcohol and cardiovascular disease: what is the relationship. // Brit.J.Addiction. - 1990. - № 7 (85). - C. 851–853.178. Urbano-Marquez A., Estrich R., Navarro-Lopez F., Grau J.M. Effects of alcoholon cardiac and skeletal muscle.
// NewEnglJMed. - 1989. - № 320. - C. 409–15.179. Valeriano, V., Funaro, S., Lionetti, R., Riggio, O., Pulcinelli, G., Fiore P.Modification of cardiac function in cirrhotic patients with and without ascites. // AmJ Gastroenterol. - 2000. - № 95. - C. 3200–3205.180. Ward C.A., Liu H.
Altered cellular calcium regulatory systems in a rat model ofcirrhotic cardiomyopathy. // Gastroenterology. - 2001. - № 121. - C. 1209–1218.181. Wehmeyer M.H. High Rate of Cardiac Abnormalities in a Postmortem Analysisof Patients Suffering From Liver Cirrhosis // Journal of Clinical Gastroenterology. 2015. - № 10 (49). - C.
866–872.182. Whyte M. Analysis of intrapulmonary right to left shunt in the hepatopulmonarysyndrome // Journal of Hepatology. - 1998. - № 1 (29). - C. 85–93.183. Wong F., Girgrah N., Graba J., Allidina Y. The cardiac response to exercise incirrhosis // Gut. 2001. № 49. C. 268–275.184. Wong F, Liu P, Allidina Y. Pattern of sodium handling and its consequences inpatients with preascitic cirrhosis. // Gastroenterology. - 1995.
- № 108. - C. 1820–1827.113185. Wong F. Cirrhotic cardiomyopathy. // Hepatol Int. - 2009. - № 3.- C. 294–34.186. Wong, F., Liu, P., Lilly, L., Bomzon, A., Blendis L. Role of cardiac structuraland functional abnormalities in the pathogenesis of hyperdynamic circulation andrenal sodium retention in cirrhosis. // ClinSci. - 1999. - № 97.
- C. 259–267.187. Woo J.J. N-terminal Pro B-type Natriuretic Peptide and the Evaluation ofCardiac Dysfunction and Severity of Disease in Cirrhotic Patients // Yonsei MedicalJournal. - 2008. - № 4 (49). - C. 625.188. Wroński J. Retrospective analysis of liver cirrhosis influence on heart wallsthickness // Pathology - Research and Practice. - 2015.
- № 2 (211). - C. 145–149.189. Yildiz R., Yildirim B., Karincaoglu M., Harputluoglu M. Brain natriureticpeptide and severity of disease in nonalcoholic cirrhotic patients. //JgastroenterolHepatol.- 2005. - № 20. - C. 1115–20.190. Ytting, H., Henriksen, J.H., Fuglsang, S., Bendtsen, F., Møller S. Prolonged Q–T(c) interval in mild portal hypertensive cirrhosis // Hepatology. - 2005.- № 43. - C.637–644.191. Zambruni, A., Trevisani, F., Di Micoli, A., Savelli, F., Berzigotti, A., Bracci E.Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. //Hepatology. - 2008.
- № 48. - C. 415–42.192. Zardi E.M., Abbate A., Zardi D.M., Dobrina A., Margiotta D., Van TassellB.W., Afeltra A. Cirrhotic cardiomyopathy // J Am Coll Cardiol. - 2010. - № 56. - C.539–549.193. Global status report on alcohol and health. 2014.114.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
